Novavax financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

노바백스NASDAQ:NVAX · Nasdaq · Healthcare

$10.46-1.32%

2026-10-02 close

Novavax's published financial data is dated 2026-10-04. 2024 revenue was $682M. 2024 operating profit was −$249M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy